Category

• Business1
• Pipeline1

Organizations

• Bausch + Lomb64
• Alcon, Inc.43
• Eyes On Eyecare43
• American Optometric Association34
• Harrow28
• Glaukos26
• Regeneron22
• Topcon Healthcare22
• Aldeyra Therapeutics20
• Sight Sciences19

Tags

• Dry Eye Disease2
• Fecd1
• Clinical Trials1
• Dry Eye1
• Eye Drops1
• Finance1

• Organizations: Invirsa✕

Clear all

Business

Invirsa secures $7.7 million in funding to advance ocular candidate

Financing will support a series of phase 2 studies for the company’s lead asset: INV-102.

Pipeline

Enrollment concludes for Invirsa's first-in-human DED study

Lead compound INV-102 is formulated to promote ocular DNA repair.